# Evaluation of the Effect of Citicoline and Docosahexaenoic Acid (DHA) on the Visual Function of Patients With Glaucoma

> **NCT05527106** · NA · COMPLETED · sponsor: **Institut Catala de Retina** · enrollment: 73 (actual)

## Conditions studied

- Glaucoma

## Interventions

- **DIETARY_SUPPLEMENT:** Citicoline
- **DIETARY_SUPPLEMENT:** Docosahexaenoic Acid (DHA)
- **DIETARY_SUPPLEMENT:** Citicoline and Docosahexaenoic Acid (DHA)
- **DIETARY_SUPPLEMENT:** Vitamin C

## Key facts

- **NCT ID:** NCT05527106
- **Lead sponsor:** Institut Catala de Retina
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03-12
- **Primary completion:** 2022-05-25
- **Final completion:** 2022-05-25
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2022-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05527106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05527106, "Evaluation of the Effect of Citicoline and Docosahexaenoic Acid (DHA) on the Visual Function of Patients With Glaucoma". Retrieved via AI Analytics 2026-07-30 from https://api.ai-analytics.org/clinical/NCT05527106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*